Langerhans cells (LCs) are dendritic epidermal cells whose ability to function as accessory/stimulatory cells in initiating the immune response is, like that of macrophages, dependent on the expression of class II major histocompatibility antigens. In normal human skin approximately 50% of LCs identified by cell surface T6 antigenicity also express HLA-DR histocompability determinants. We report here that recombinant DNA-derived human interferon (IFN)-gamma, but not IFNalpha2, induces the expression of HLA-DR antigens by the population of human epidermal LCs on which such antigens normally are not detected. IFN-gamma effectively induced HLA-DR on both neonatal and adult epid e rmal LCs and such induction was blocked by neutralization with a murine monoclonal antibody to IFNgamma. IFN-gamma induction of LC HLA-DR expression is inhibited by prostaglandin E2 (PGE 2 ) and is mimicked by the presence of fatty acid cyclooxygenase inhibitors, known to reduce PGE2 production. These results suggest that IFN-gamma may play a role in regulating skin-associated immune responses through enhanced expression of HLA-DR antigens on LCs and that such enhancement may be mediated by alterations in arachidonic acid metabolism.
Langerhans cells (LCs) are dendritic epidermal cells whose ability to function as accessory/stimulatory cells in initiating the immune response is, like that of macrophages, dependent on the expression of class II major histocompatibility antigens. In normal human skin approximately 50% of LCs identified by cell surface T6 antigenicity also express HLA-DR histocompability determinants. We report here that recombinant DNA-derived human interferon (IFN)-gamma, but not IFNalpha2, induces the expression of HLA-DR antigens by the population of human epidermal LCs on which such antigens normally are not detected. IFN-gamma effectively induced HLA-DR on both neonatal and adult epid e rmal LCs and such induction was blocked by neutralization with a murine monoclonal antibody to IFNgamma. IFN-gamma induction of LC HLA-DR expression is inhibited by prostaglandin E2 (PGE 2 ) and is mimicked by the presence of fatty acid cyclooxygenase inhibitors, known to reduce PGE2 production. These results suggest that IFN-gamma may play a role in regulating skin-associated immune responses through enhanced expression of HLA-DR antigens on LCs and that such enhancement may be mediated by alterations in arachidonic acid metabolism.
The major hi stocompat ibility complex encodes for two classes of cell surface glycop roteins. In human s these membrane proteins are class 1 (HLA-A, B, C) and class II (HLA-DR, DS, SB) molecu les [1 -3 ] . In contrast to class I antigens which are expressed upon most somati c cel ls except adu lt erythrocytes, class II ant igens have a restricted cellular distribution. The most exten sive ly studied class II antigen, HLA-DR, for example, is norma ll y expressed onl y by B cells and accessory cells suc h as monocytes, macrophages, dendritic ce lls, a nd Laagerhans cell s (LCs) (4) (5) (6) (7) . HLA-DR molecules are homologous structurall y and functiona lly with murine Ia surface glycoproteins (8] , and are fun ctionally important in that their expression is required for accessory cells to present nominal antigen to helper T cell s and initi ate the immune respon se [9] [10] [11] [12] [13] HLA-DR molecules are also important as stimulatory antigens in triggering mixed lymphocyte reactions [9] and mixed epidermal cell-lymphocyte reactions [1 2,13 ] . Several studies in both the human and murine systems have indicated that expression of DR/la antigens upon B cells and macrophages can be stimulated by soluble products of activated T cells [14] [15] [16] [17] . Specifically, recent studies have identified the DR/la inducing lymphokine as interferon (IFN) -gamm a, and have shown that IFN-gamma produced from the cloned IFNgamma gene is capable of such DR/la induction [18] [19] [20] . Both IFN -a lpha and IFN-beta appear to be either less effective or ineffective as DR/la inducers (21, 22] .
LCs, which are derived from bone marrow precursor cells [23] and reside within the epidermis, share many characteristics with rnacrophages inducing DR/la expression [6, 7) and accessory cell functions [10] [11] [12] [13] 24) . LCs are the on ly cells in the normal human epidermis to express DR-antigen and the cell surface antigen T6, a molecule a lso found on 70 % of human thymocytes [25] . Just as not all macrophages express DR antigens, using immunofluorescent microscopic techniques, we and others have found that approximately 50 % of TG bearing LCs do not express detectable levels of DR a ntigens [26] [27] [28] . In this study we report a selective enhancement of HLA-DR expression on human epidermal LCs that is effected by exposure to recombinant DNA-derived IFN-gamma, but not to IFNaJpha2.
The intracellular mechanisms responsible for IFN-gamma induction of DR/la antigens are unknown, but studies with murine macrophages suggest that products of the arachidonic acid cascade are involved as prostaglandins of the E series (PGE) were reported to inhibit lymphokine-induced Ia expression [18, 29] . Moreover, the cyclooxygenase inhibitor, indomethac in, mimicked lymphokine action by inducing macrophage la expression by itself (29] . Similarly, we report here that PGE2 inhibits the IFN-gamma induced HLA -DR expression on LCs and further demonstrate that indomethacin and 3 other cyclooxygenase inhibitors can mimic IFN -gamma action by increasing HLA -DR expression on LCs.
MATERIALS AND METHODS

Interferons an.d Anti-Interferons
Human recombinant IFN -alpha, (6.6 x 10 7 units/ml) from 2 , and indomethacin were dissolved in absolute ethanol and diluted in RPMI-10% heat-inactivated fetal calf serum (.6FCS) to the fi nal tested concentrations. At the dilutions tested ethanol had no effect on HLA-DR expression. Benoxaprofen, ETYA, and NDGA were dissolved in minimal amounts of l N NaO H, immediately neutrali zed with 1 N HCl, a nd diluted (as was imidazole directly) in RPMI-10% 6 FCS to the fin al conce ntratio ns des ired.
TABL E I. Expression of Langerhans cell HLA -DR antigens following exposure of dispersed epidermal cells to IFN-a/ph.a. 2 and IFN-gamma.
DW/ T6• Lan -
Dispersed Epidermal Cell Cultures
Dispersed epidermal cells (5 x 10 5 ) isolated from neo natal huma n fores kin as desc ribed in [7) , were main tained in vitro at 37·c for 20 h in humidified 5% C0 2 in 2.0 ml RPMI-1640 containing 10 % llFCS and t he indicated concentrations of either pure, E . coli reco mbinant DNA derived human IFN -alpha2, IFN-gamma, or other compounds as indicated. Dispersed epidermal cells from adult facial skin were isolated a nd maintained as indicated above in 3 separate experiments.
Detection of L C Surface Antigens HLA -DR and T6 on Dispersed Epidermal Cells
Simultaneous detection of HLA-DR and T6 antigen-bearin g cells was ach ieved under epifluorescent microscopy following sequential t reatment of the epidermal cells with mouse monoclonal anti-HLA-DR IgG, (Ortho Diagnostics, Ra ri tan, New J ersey) , rhodaminated goat a ntimouse IgG (Meloy Labs, Springfield, Virginia), mouse monoclonal anti-T1 IgG (to saturate free antimouse IgG binding sites), a nd fluoresceina ted mouse monoclo nal anti-T6 lgG (Ortho Diagnostics) [26) . Epidermal cells were examined as wet mounts under epifluorescent microscopy with appropriate excitatory and barrier filters and the mea n number, a nd SD, of DR+ / T6+ cells were calculated.
Skin Explant Incubatio n In Vitro
Four millimeter-diameter specimens of freshly excised human neonatal foreskin, trimmed of fat and dermis, we re maintained in vitro under co nditions identical to t hose described for dispersed epidermal cells. After 20 h in cul ture, in tact epidermal sheets were prepared from each specimen foll owing incubation in 1 N NaBr at 37•c for 60 min. Adult facial skin prepared and maintained under these co nditions was utilized in 2 separate experiments.
Detection of HLA-DR Bearing LC in Epidermal Sheets
Epiderm al sheets were incubated with either mouse monoclonal anti-HLA-DR IgG or anti-T6 IgG (Ortho Diagnostics) followed by incubation with fluoresceina ted goat antimouse lgG (Meloy Labs), at 23 · c [26] . The number of fluorescing, dendritic cells in ten 400 x fi elds was counted under epifluorescent mic roscopy and a mean and SEM per mm 2 calculated.
Statistics
The statistical difference between means was calculated using the Student's one-tailed t-test with probability values less than 0.01 being considered significant.
RESULTS
E ffect of Interferons on Expression of HLA-DR Antigens by Dispersed Epidermal Cells
To determine their effects on surface HLA-DR expression, E. coli-derived IFN -alpha 2 and IFN-gamma were tested initially on cultured neonatal human epidermal cells. LCs constitute 2-5 % of human epidermal cells [30] and, within the epidermis, may be specifically ide ntified by t he presence of cell surface T6 a n tigen [25] . We [26] and others [27, 28] have reported t hat only half of T6-positive LCs also express HLA-DR antigens. As s hown in Table I , the addition of IFN-gamma to huma n epidermal cell cultures increased the number of DR+ /T6+ LCs detected, even at the lowest conce n tration (10 units/ml) tested. • Significantly different (p < 0.01) from untreated control. o Four millimeter-diameter specimens of freshly excised human neonatal foreskin, trimmed of fa t and dermi s, were maintained in vitro as described in Materials and M ethods.
• Epidermal sheets were stained by indirect immunofluorescence for HLA-DR bearing cells as described in Maten:als and M ethods. The number of flu orescing, dendritic cells in 10 fields were coun ted under epifl uorescent microscopy (400X) and a mean and SEM per mm 
Effect of Interferons on Expression of HLA-DR Antigens on LCs in Situ
To further approximate in vivo conditio ns and to avoid enzymatic treatments and other physical manipulat ions required to isolate and disperse epidermal cells for culturing (7] , superficial specimens of human foreskin were maintained in culture for 20 h in the absence and presence of various concentrations of IFN -gamma and IFN-alphaz. Following treatment of t he specimens with NaBr, t he number of DR a nd T6 a ntigenbearing cells per mm 2 in the resultant epidermal sheets was calculated. As shown in Table II, exposure to IFN-gamma (10   1  - 105 units/ml) enhanced t he detection of DR antigen-bearing epidermal cells with no increases being detected fo llowing t he additio n of identical concentrations of IFN-alpha 2 • All DRbearing cells were dendritic, and T6 antigen -bearing LCs were not increased in number. The IFN 7 gamma en ha ncemen t of DR-bearing LCs was not restricted to neonatal epidermal cells but a lso occurred when adu lt epidermal cells were studied. In 3 experimen ts utilizing a dult face s kin epidermal cell cultures, incubation with 10 "Nine separate experiments were carried out in which human foreskin specimens were prepared, cultured, and analyzed for epidermal HLA-DR antige nicity as described in Materials and M ethods, employing 10 3 units/ ml IFN -gamma.
• Each value listed in this column is significantly different (p < 0.01) from its corresponding untreated control value.
antigen-bearing LCs over control specimens by 77.9 % ± 4.3 (SEM) . Extending the duration of incubation with IFN-gamma to 48 h did not result in any further increases in HLA-DR+ LCs.
As observed with dispersed epidermal cell cu ltures, IFNgamma also enha nced the expression of HLA-DR by LCs in situ in adult skin specimens. In 2 separate experiments using specimens of adult face skin, incubation with 10 3 units IFNgamma increased the number of in situ DR+ cells/mm 2 by an average of 80% over controls.
Inhibition of IFN-gamma Enhancement of LC HLA -DR Expression by Monoclonal Anti-IFN-gamma
To be certain t hat cloned IFN -gamma itself and not some 
Inhibition of IFN-gamma Induced HLA-DR Expression on
LCs by PGE 2 PGE, and PGE 1 , both products of fatty acid cyclooxygenase action on arachidonic acid, inhibit lymphokine-induced murine macrophage expression of Ia antigens [18, 29] . These findings prompted us to determine whether PGE 2 could inhibit optimal induction by IFN-gamma of HLA-DR expression on LCs contained in cu ltured foreskin specimens. As s hown in Table IV , 10-7 M PGE 2 effectively inhibited the HLA -DR expression induced by 10 3 units IFN-gamma/ml, while TXB2 had no such inhibitory activity. This observation suggests that IFN-gamma may be inducing HLA -DR expression on LCs by inhibiting the synthesis of PGE2.
Enhancement of LC HLA-DR Antigenicity by Fatty Acid Cyclooxygenase Inhibitors
In order to demonstrate that inhibition of PGE2 synthesis can result in enhanced expression of HLA-DR a ntigen on LCs,
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we investigated whether compounds inhibiting PGE 2 synthesis via in hibition of fatty acid cyclooxygenase could in the absence of exogenously added IFN-gamma increase HLA-DR expression. Foreskin specimens were maintained either in RPM! alone or in RPMI containing IFN-gamma at 10 3 units/ml, in the presence or absence of known inhibitory concentrations of indomethacin, a specific cyclooxygenase inhibitor [31] or benoxaprofen, ETYA, and NDGA, compounds which inhibit both the cyclooxygenase and lipoxygenase metabolism of arachidonic acid [32] [33] [34] . As shown in Fig 1, a ll "Human foreskin specimens were prepared, cu ltured, and analyzed for epidermal HLA-DR antigenicity as described in Materials and M ethods and the number of HLA-DR+ LCs expressed as a percentage of those present in the untreated control. Superficial foreskin specimens were prepared and maintained as described in Materials and Methods in the absence or presence of the compounds indicated. The bars represent the mean ± SEM of 16 separate experiments for controls, 8 experiments for indomethacin (10- itors of PGE 2 synthesis mimic the action of IFN -gamma inducing HLA-DR a nt igen expression on LCs, a situation having been prev iously reported for murine macrophages [29] . Incubation in t he presence of imidazole, a relatively selective inhibitor of thromboxane synthetase, failed to induce HLA-DR expression [35] .
DISCUSSION
We have studied the effects of cloned IFN-gamma and IFNalpha2 upon the expression of HLA-DR histocompatibility antigens by hum an epidermal cells maintained in vitro as suspension cultures and as intact skin explants. The data presented show that cloned human IFN-gamma, but not IFN-alpha 2 , increases the number of epidermal cells expressing HLA-DR antigens approximately 2-fold after 20 h of exposure. HLA-DR was induced only on LCs as only T6-positive cells expressed HLA-DR antigen, and t he total number of OR-positive cells (constitutive + induced) never exceeded the number of T6-positive LCs present. Whether IFN-gamma, in addition to inducing the presence of HLA-DR determinants on DR-/T6+ LCs, can also increase the degree of expression of HLA-DR on DR+ /T6+, as has been reported for human monocytes [20] , cannot be determined by simple immunofluorescent microscopy. However, the induction of HLA-DR antigens by IFNgamma (and not by IFN -alphaz) on DR-/T6+ LCs is consistent with similar inductions reported on other macrophage and macrophage-like cells otherwise expressing low or undetectable levels of DR-antigens [15] [16] [17] [18] 22) . Although recent reports indicate that IFN-gamma may also induce HLA-DR expression on epidermal keratinocytes, such induction reportedly required 4-8 days' incubation and was never observed to occur in our short-term (20 h) cultures [36) .
The in tracellular mechanisms responsible for IFN-gamma induction of LC HLA-DR expression have also been investigated and our results suggest that IFN-gamma may act by inhibiting the synthesis of PGE 2 • This conclusion was based on our observations that (1) PGE 2 inhibited IFN-gamma induction of HLA-DR, and (2) compounds inhibiting PGEz production via blockade of fatty acid cyclooxygenase can increase HLA-DR expression on LCs in the absence of IFN-gamma. These results are again consistent with previous results concerning Ia induction in murine macrophages [18, 29) . The actions of IFN -gamma and fatty acid cyclooxygenase inhibitors were not additive, but at the concentrations tested each agent alone induced the numbers of HLA-DR bearing LCs to approach the tota l number of T6-positive LCs. At lower concentrations such additive effects, if present, may be detected.
The question of whether IFN -gamma acts directly on LCs to inhibit PGE2 production or indirectly via inhibiting PGE2 production by other epidermal cells such as keratinocytes has not been addressed in this study. However, preliminary results using T6-positive LCs isolated by panning techniques [37) indicate IFN-gamma acts directly on LCs to increase HLA-DR expression. Such a direct mechanism of action would be consistent with recent reports indicating IFN-alpha and IFN -beta act directly on macrophages and monocytes to inhibit prostaglandin synthesis by blocking phospholi pase activation [38, 39) . However, additional experiments are required to determine the exact role of arachidonate metabolites in constitutive and IFN-gamma induced HLA-DR expression by epidermal LCs.
Epidermal LCs function as stimulator cells of allogeneic Tcell activation and as antigen-presenting cells in antigen-induced T-cell proliferation and in cytotoxic T-lymphocyte generation [10] [11] [12] [13] 24) . These immune functions are genetically restricted, being regulated by HLA-DR, or their murine equivalent, Ia, antigens. The enhancement of epidermal LC DRantigenicity following exposure to IFN-gamma (although not to IFN-alpha 2 ) may imply concomitant enhancement of DRregu lated LC functioning, as this has been reported in the case of lymphokine-induced expression of Ia determinants by murine macrophage tumor cell lines [40, 41) . LC accessory cell functions are in all likelihood active in contact hypersensitivity, skin graft rejection and certain types of drug hypersensit ivities. We are presently examining whether the induction of HLA-DR antigens on LCs by IFN-gamma results in an increase in LC accessory /stimulatory cell functions.
